Introduction: Here we present the case of a 27-year-old SLE sufferer with NPSLE, who hadpositive serological tests forboth CMV andmumps. These were both subsequently confirmed to be false positives by polymerase chain reaction (PCR). While false positive CMV serology in the context of SLE has already been reported in the literature, there has been noreport of asimilar phenomenonfor mumps. Case description: A 27-year-old female was admitted with acute confusion, dysarthria and somnolence. Three days prior to admission she had received a diagnosis of systemic lupus erythematosus in a rheumatology outpatient clinic having been referred with a six month history of arthralgia primarily affecting the knees and small joints of the hands; she had been found to have elevated antibodies against double stranded DNA (dsDNA) and was commenced on prednisone 10 mg daily and hydroxychloroquine 200 mg daily. Over the next three days, she developed progressive confusion and fluctuating somnolence. Upon admission to hospital, examination revealed a GCS of 14 (E4V4M6), equal and reactive pupils, symmetrical facial movements, dysarthric speech, globally brisk tendon reflexes and an extensor plantar response bilaterally. No rashes were noted. Examination of the oral mucosa did not reveal the presence of apthousulcers.Examination of the joints revealed nil active synovitis. She was found to be anaemic (haemoglobin 93g/L, reference range 120-156g/L), leukopaenic (2.10 x10*9/L, reference range 3.9-10.2 x10*9/L) and lymphopaenic (0.18 x10*9/L, reference range 1.10-4.50 x10*9/L). The platelet count was normal (240 x10*9/L, reference range 150-370 10*9/L). The direct antiglobulin test was positive. She was strongly positive for anti-nuclearantibodies (ANA >1/1000) with a homogenous HEp-2 staining pattern and significantly elevated anti-double stranded DNA titres (>400 IU/ml, reference range 0-10 IU/ml) and had hypocomplementaemia (C3 0.20g/l, reference range 0.75-1.65g/l, C4 0.03, reference range 0.14-0.54g/l). Testing for extractable nuclear antigens was negative (RNP, Sm, Ro, La, Scl, Jo1 & centromere). Clotting studies revealed a prolonged activated partial thromboplastin time (APTT 38 seconds, reference range 25.8-35 seconds) with a normal prothrombin time. MRI imaging of the head revealed multiple areas of T2 hyperintensity, contrast enhancement and restricted diffusion. A CT cerebral angiogram revealed irregularity of the left posterior cerebral artery, distal branches of the left middle cerebral artery pericallosal vessels, findings consistent with an intracranial vasculitis. A CT pulmonary angiogram revealed incidental bilateral segmental pulmonary emboli with resulting pulmonary infarction. Testing for anti-phospholipid antibodies revealed a positive lupus anticoagulant, positive anti-cardiolipin IgM (47 mplu/ml, reference range 0-9 mplu/ml) and IgG (12 gplu/ml, reference range 0-9 gplu/ml) and positive beta-2-glycoprotein-1 IgM (10 u/ml, reference range 0-6 u/ml) and IgG (8 u/ml, reference range 0-6 u/ml). Serological testing was negative for Borrelia burgdoferi IgG, Aspergillus galactomannan antigen, EpsteinBarr virus IgG and IgM, hepatitis B core antibody, hepatitis B surface antigen, HIV antibody, HIV antigen, toxoplasma IgG, and Treponemal antibody. CSF analysis showed a normal opening pressure (16cmH2O, reference range 0-20cmH2O), elevated protein (1.04g) lymphocytosis (66 lymphocytes, reference range 0-5), decreased glucose (CSF glucose 1.3mmoml/L, serum glucose 4.7 mmol/L) mildly increased neutrophil count (8, reference range 0-5), and a red cell count 48. No organisms were seen on a Gram stain or Ziehl-Neelsen stain, viral PCR was negative for herpes zoster, varicella zoster and adenovirus and CSF culture, including mycobacterial culture, revealed no growth. CSF cytology revealed lymphocytosis with some evidence of lymphophagocytosis. A provisional diagnosis of active systemic lupus (SLEDAI-2K score 44) with cerebral lupus with secondary CNS vasculitis and probable anti-phospholipid syndrome. Uponpresentationempiricalceftriaxoneand acyclovirwerecommenced to cover for a meningoencephalitis. These were discontinued following
Introduction: Here we present the case of a 27-year-old SLE sufferer with NPSLE, who hadpositive serological tests forboth CMV andmumps. These were both subsequently confirmed to be false positives by polymerase chain reaction (PCR). While false positive CMV serology in the context of SLE has already been reported in the literature, there has been noreport of asimilar phenomenonfor mumps. Case description: A 27-year-old female was admitted with acute confusion, dysarthria and somnolence. Three days prior to admission she had received a diagnosis of systemic lupus erythematosus in a rheumatology outpatient clinic having been referred with a six month history of arthralgia primarily affecting the knees and small joints of the hands; she had been found to have elevated antibodies against double stranded DNA (dsDNA) and was commenced on prednisone 10 mg daily and hydroxychloroquine 200 mg daily. Over the next three days, she developed progressive confusion and fluctuating somnolence. Upon admission to hospital, examination revealed a GCS of 14 (E4V4M6), equal and reactive pupils, symmetrical facial movements, dysarthric speech, globally brisk tendon reflexes and an extensor plantar response bilaterally. No rashes were noted. Examination of the oral mucosa did not reveal the presence of apthousulcers.Examination of the joints revealed nil active synovitis. She was found to be anaemic (haemoglobin 93g/L, reference range 120-156g/L), leukopaenic (2.10 x10*9/L, reference range 3.9-10.2 x10*9/L) and lymphopaenic (0.18 x10*9/L, reference range 1.10-4.50 x10*9/L). The platelet count was normal (240 x10*9/L, reference range 150-370 10*9/L). The direct antiglobulin test was positive. She was strongly positive for anti-nuclearantibodies (ANA >1/1000) with a homogenous HEp-2 staining pattern and significantly elevated anti-double stranded DNA titres (>400 IU/ml, reference range 0-10 IU/ml) and had hypocomplementaemia (C3 0.20g/l, reference range 0.75-1.65g/l, C4 0.03, reference range 0.14-0.54g/l). Testing for extractable nuclear antigens was negative (RNP, Sm, Ro, La, Scl, Jo1 & centromere) . Clotting studies revealed a prolonged activated partial thromboplastin time (APTT 38 seconds, reference range 25.8-35 seconds) with a normal prothrombin time. MRI imaging of the head revealed multiple areas of T2 hyperintensity, contrast enhancement and restricted diffusion. A CT cerebral angiogram revealed irregularity of the left posterior cerebral artery, distal branches of the left middle cerebral artery pericallosal vessels, findings consistent with an intracranial vasculitis. A CT pulmonary angiogram revealed incidental bilateral segmental pulmonary emboli with resulting pulmonary infarction. Testing for anti-phospholipid antibodies revealed a positive lupus anticoagulant, positive anti-cardiolipin IgM (47 mplu/ml, reference range 0-9 mplu/ml) and IgG (12 gplu/ml, reference range 0-9 gplu/ml) and positive beta-2-glycoprotein-1 IgM (10 u/ml, reference range 0-6 u/ml) and IgG (8 u/ml, reference range 0-6 u/ml). Serological testing was negative for Borrelia burgdoferi IgG, Aspergillus galactomannan antigen, EpsteinBarr virus IgG and IgM, hepatitis B core antibody, hepatitis B surface antigen, HIV antibody, HIV antigen, toxoplasma IgG, and Treponemal antibody. CSF analysis showed a normal opening pressure (16cmH2O, reference range 0-20cmH2O), elevated protein (1.04g) lymphocytosis (66 lymphocytes, reference range 0-5), decreased glucose (CSF glucose 1.3mmoml/L, serum glucose 4.7 mmol/L) mildly increased neutrophil count (8, reference range 0-5), and a red cell count 48. No organisms were seen on a Gram stain or Ziehl-Neelsen stain, viral PCR was negative for herpes zoster, varicella zoster and adenovirus and CSF culture, including mycobacterial culture, revealed no growth. CSF cytology revealed lymphocytosis with some evidence of lymphophagocytosis. A provisional diagnosis of active systemic lupus (SLEDAI-2K score 44) with cerebral lupus with secondary CNS vasculitis and probable anti-phospholipid syndrome. Uponpresentationempiricalceftriaxoneand acyclovirwerecommenced to cover for a meningoencephalitis. These were discontinued following CSF analysis. Upon making the diagnosis of active lupus therapeutic low molecular weight heparin (tLMWH), pulsed intravenous methylprednisolone (IVMP) therapy and plasma exchange were commenced. Five consecutive plasma exchanges were performed with normal saline and human albumin solution used as the replacement fluid. Fresh frozen plasma was used instead of human albumin solution for the third exchange because of transient hypofibrinogenaemia (1.07 g/L, reference range 1.46-3.33 g/L. The patient's clinical picture remained unchanged. It was decided to escalate therapy to pulsed intravenous cyclophosphamide (CYC), however this was delayed by three days because of concerns of an alternative diagnosis of a viral encephalitis, because she had positive serology for cytomegalovirus (CMV) IgM & IgG and Mumps IgM & IgG. Confirmation of infection was sought through PCR of blood and CSF. In house testing for CMV PCR in the blood was negative. Mumps PCR tests were delayed because these are done at an external laboratory. It was decided that treatment with cyclophosphamide should start even without this test result, because it emerged that she had received the mumps, measles and rubella (MMR) vaccine in 1990 and the clinical picture was felt not to be in keeping with a mumps encephalitis. She had intravenous pulsed cyclophosphamide therapy as per the CYCLOPS regimen. Subsequent mumps PCR was negative in both salivary and cerebrospinal fluid samples. Pulsed cyclophosphamide and oral steroids were continued. The clinical picture improved with improving neurological function and improved MRI appearances. The positive mumps IgM and CMV IgM serologicalresults wereattributed to false positives in the context of active systemic lupus erythematosus with positive anti-phospholipid antibodies.The clinical picture gradually improved over the following two weeks with improving neurological function and resolving MRI appearances. The positive mumps IgM and CMV IgM serological results were attributed to false positives in the context of active systemic lupus erythematosus with positive antiphospholipid antibodies. The patient's care was transferred from our tertiary unit to her local hospital where she completed pulsed cyclophosphamide as an outpatient followed by the introduction of mycophenolate mofetil. She was lost to further follow up at this hospital. Discussion: The interplay between autoimmune diseases and infections is a complex one, and the serological diagnosis of infections in individuals suffering from autoimmune diseases-especially lupus-is not straightforward, owing to the possibility of false positive results on serological tests. This has been well reported for a number of infectious diseases, such as HIV, syphilis, toxoplasmosis and CMV, in the context of SLE. In this report, we described a young patient who had positive serology for both CMV and mumps. Subsequent negative PCR results confirmed that these were false positives. While false positive CMV serology has already been reported in the literature, there has been no reports of false negative mumps serology. False positive CMV serological results have been reported in the context of SLE, both in pregnant women and outside pregnancy. Similarly, false positive serology for syphilis in SLE has been recognised for a long time, having been first reported back in the 1950's. Others have reported similar findings since then. False positive HIV serology has also been reported in SLE patients, while false positive Lyme disease serology in SLE patients is not uncommon, with one study reporting incidence as high as 40%. The mechanisms underlying false positive serology in these different contexts have not been fully elucidated, but it is likely that a common mechanism underlies this phenomenon. The most likely mechanism involves dysregulated B lymphocyte proliferation and differentiation, which is likely to result in the production of a diverse range of anti-viraland anti-bacterial antibodies in addition to non-specific sticky immunoglobulins that give high backgrounds on serological assays and arethereforemisdiagnosedaspositive.Two majortypesoftests forsyphilis are commonly used; treponemal and non-treponemal. The nontreponemal tests detect anti-treponemal antibodies using a cardiolipin/ lecithin/cholesterol mixture. As a consequence of the nature of the antigens that these tests utilise, they are associated with a relatively high rate of false positives in autoimmune conditions such as lupus. This has been explained by the observation that anti-dsDNA and anti-single stranded DNA (anti-ssDNA) antibodies are able to cross-react with phospholipids, including cardiolipin. While treponemal tests are thought to have higher specificities than non-treponemal tests, false positive results have been reported for treponemal tests in the context of SLE as well. For example, serum obtained from SLE patients tested using the fluorescent treponemal antibdy-absorption (FTA-ABS) test was found to result in a beaded appearance, in contrast with the more homogeneous appearance expected in someone truly positive for syphilis. This beaded pattern was therefore recognised as being indicative of afalse positive result.It islikely that this atypical pattern on FTA-ABS was the result of cross-reactive autoantibodies in the SLE patients' serum. There is evidence for polyclonal B cell activation underlying false positive serology for HIV in SLE as well. It was observed that antibodies cross-reactive to HIV p24 gag protein could be found in SLE patients' serum. Indeed, antibodies directed against HLA-DRmolecules (anMHC classIIreceptor) have beenreported to be present in SLE patients' serum, and there is significant sequence homology between MHC class II receptors and HIV antigens, which may explain the aforementioned cross-reactivity. Similarly, the false positive results on Borrelia ELISAs have been suggested to be due to either the non-specific binding of SLE immune complexes to microtitre wells, or the non-specific cross-reactivity of autoantibodies found in SLE to Borrelia antigens (either cytoplasmic or nuclear, or both) in microtitre wells. Alternative explanations have been proposed, which speculate on the presence of other infections that may result in the production of crossreactive antibodies. For example, false positive CMV serology in the context of SLE has been postulated to be due to the presence of another infection, e.g. Epstein-Barr virus (EBV), which might be able to result in a polyclonal B cell reaction. Thus, anti-CMV antibodies may be produced, thereby giving false positive reactions. Antibodies directed against other herpes viruses also appear to show significant cross-reactivity, which could potentially explain CMV false positive serologyin individuals suffering from other herpes infections. Similarly, false positive HIV serology in SLE patients has been proposed to be linked to a possible role for retroviruses in the pathogenesis of SLE. HIV is considered unlikely to be the retrovirus in question but, due to significant homology between retroviruses, it is likely that an SLE sufferer who might have an associated retroviral infection would possess antibodies against the aforementioned retrovirus that would also be cross-reactive to HIV antigens. To conclude, there was a delay in this patient receiving immunotherapy for her lifethreatening cerebral lupus because of a failure to recognise that positive serology results for both CMV and mumps might be false positive, as subsequently confirmed when PCR analysis was performed. False positive CMV serology has been previously reported in SLE, and the possible mechanisms underlying this phenomenon were discussed above. False positive mumps seroreactivity in SLE patients, on the other hand, has so far not been reported in the literature. However, given the non-specific polyclonal nature of the B lymphocyte response induced by SLE and the diversity of autoantibodies found in SLE, it is possible that SLE patients may possess a number of antibodies capable of cross-reacting with mumps antigens, thereby resulting in false positive results on mumps serology tests. It is important for clinicians to recognise the possibility of false viral serology in people with lupus to avoid unnecessary delays in administering immunotherapy. Introduction: Takayasu arteritis is a well-known, yet rare form of large vessel vasculitis with predominance in countries such as India and Japan. It is usually detected in young females aged 20-40, with the most common manifestation of claudication pain and fever of unknown origin. Neurological manifestations are common but rarely present as the first presenting symptom. The reported incidence of neurological manifestations including headache, dizziness, visual disturbance or loss of consciousness, stroke, and transient ischemic attack (TIA) varies from 57% up to 80%. Vasculitis can manifest primarily with striking leptomeningeal involvement as shown in various case reports of ANCA-associated vasculitis and primary CNS angitis. As Takayasu arteritis primarily affects proximal large vessels, leptomeningeal involvement seems theoretically unusual.Here,wereport acaseofnodular leptomeningitisas apresenting manifestation of Takayasu arteritis. Case description: This is a case of a 23 year old female without any prior comorbidity who developed high-grade fever associated with headache and diffuse body ache in September 2017. Fever was not associated with sore throat, cough, burning micturition, altered bowel habits, night sweats or any other localising signs. She was started on azithromycin along with anti-pyretic, but continued to have daily spikes of fever. On the fifth day of illness, she developed altered sensorium. It was not preceded by excruciating headache or vomiting. It was not associated with seizure, arm/leg weakness or abnormal moments. She was taken to a higher centre where on examination she was found to have elevated blood pressure [210/150 mmHg]. She was started on intravenous antihypertensives and in view of altered sensorium; she underwent contrast enhanced computed tomography of the brain, which revealed hydrocephalus with dilated lateral and third ventricle and leptomeningeal enhancement.Shewasreferredtoatertiary carecentre forfurtherevaluation and management. She was brought to the emergency department of our hospital on fifth day of illness. She was febrile and had elevated BP [200/110 mmHg] at time of admission despite being on intravenous antihypertensives. Her GCS was 6/15. Her general examination was unremarkable and respiratory and cardiovascular system examinations were normal. Neurological examination did not show any particular abnormality except bilateral extensor plantar response. She underwent MRI with contrast which showed nodular leptomeningeal enhancement in bilateral front parietal, occipital and right posterior temporal region. There were nodular enhancing foci in cerebellum, thalami, pons and midbrain. Fourth ventricle was compressed with resultant hydrocephalus and there was transtentorial herniationof left cerebellar hemisphere. Further historytaking revealed history of pulmonary tuberculosis in a grandfather four months prior. Based on MRI findings and family history of tuberculosis exposure, probable diagnosis of tubercular meningitis was considered. She was intubated in view of deteriorating sensorium and was started on intravenous antibiotics (ceftriaxone 2 gms twice daily) and anti tubercular treatment (isoniazid, rifampicin, pyrizinamide, ethambutol and levofloxacin) . In view of significant brain oedema and diagnosis of tubercular meningitis, intravenous steroids (dexamethasone 8 mg thrice daily) were added as well. She underwent external ventricular drainage procedure to relieve the hydrocephalus. Her drain showed clear cerebrospinal fluid which on cytological, biochemical and microbiological analysis did not reveal any significant abnormality (no evidence of mycobacterium tuberculosis). Her blood investigations revealed low Hb [8.6 gm/dl] and moderately elevated ESR and CRP [45 mm/hr and 36 mg/L]. Her Liver function, renal function, blood culture and urine cultures were sterile and 2 D echo was normal. At this point of time we were dealing with a case consisting of two cardinal issues: fever with altered sensorium for which possible explanation was tubercular leptomeningitis with obstructive hydrocephalus and accelerated hypertension in a young female. Rheumatology review was done in view of nodular enhancement in the brain with suspicion of neurosarcoidosis. After 48 hours of treatment, patient had improvement in sensorium and was extubated. This enabled us to take detailed history from patient herself. Patient said to be having on and off arthralgia and claudication pain in right upper limb for last one month. On re-examination, she was found to be having difference in pulse volume and blood pressure in both upper limbs. To substantiate the diagnosis of tubercular meningitis, repeat cerebrospinal fluid analysis was done which was normal. Her ANA, ENA, ANCA serology and RF were negative. Her serum ACE levels were normal. She was subjected to renal doppler as a part of evaluation of young hypertensive, which revealed left renal artery stenosis. She underwent contrast enhanced computed tomography of chest and abdomen with angiogram of abdominal aorta. It revealed wall thickening with luminal irregularity of infra renal aorta and right subclavian vessels. There was complete occlusion of proximal superior mesenteric artery, left renal artery and right external iliac artery along with small left kidney. Overall findings were suggestive of aortoarteritis. Meanwhile she kept on improving clinically due to intravenous steroids. Her external ventricular drain was removed and her blood pressure was controlled on a combination anti-hypertensive agents. She was switched to oral prednisolone 1 mg/kg.Her previous twoCSFsamples were taken fromventricular drains which were normal. To prove our diagnosis of tubercular meningitis, she was subjected to lumbar puncture and subsequent CSF analysis for the third time which was again normal. As her thrice repeated CSF samples were entirely normal, we became skeptical regarding our diagnosis of tubercular meningitis. But we were unable to explain nodular leptomeningitis and hydrocephalus with diagnosis of Takayasu arteritis alone. In literature review, we could not find any case describing leptomeningitis in patient with Takayasu arteritis. But we found case reports describing leptomeningitis in primary CNS angitis and ANCA-associated vasculitis. Case reports describing nodular enhancement in systemic lupus erythrematous, antiphospholipid syndrome and Behc¸et's disease were also found in the literature. In anticipation of reaching adiagnosis, we repeated MRI brain with MR angiogram of head & neck on day ten of admission. It revealed complete resolution of previously seen nodular lesions, significant decrease in oedema and mass effect, resolution of hydrocephalus and significantly narrowed bilateral middle cerebral artery and intracranial internal carotid artery. A mere course of ten days of anti tubercular treatment did not justify such a rapid resolution of nodular leptomeningitis. This enabled us to rule out coexistent tubercular meningitis. Anti tubercular therapy was discontinued. Based on adequate evidence of nodular leptomeningitis occurring in various forms vasculitis and intracranial vessel involvement well characterised in aortoarteritis patients presenting with neurological symptoms, a final diagnosis was
